ClinicalTrialsFinder

Active Moderate to Severe Rheumatoid Arthritis Clinical Trials in Seoul

1 recruitingSeoul, South Korea

Showing 1–1 of 1 trials

Recruiting

Korean Post-marketing Surveillance for Xeljanz XR

Active Moderate to Severe Rheumatoid ArthritisActive Ankylosing SpondylitisActive Psoriatic Arthritis
Pfizer200 enrolled1 locationNCT04876781